When to Consider Preventive Treatment for Migraine

Is It Time to Consider Preventive Treatment for Migraine?

Is It Time to Consider Preventive Treatment for Migraine?
Adobe Stock

For many people with migraine, treatment starts with acute medicine — something you take when an attack begins to stop the attack from progressing or to make the pain and other symptoms less severe. But when attacks become more frequent and harder to control with acute treatment, it may be time to consider preventive treatment.

“The ultimate goal of preventive or maintenance treatment is more headache-free days,” says William Howell Jarrard, MD, a neurologist and assistant professor at the Medical University of South Carolina in Charleston. Preventive treatment can also make attacks less severe and make acute medicines work better, Dr. Jarrard says.

For many people, preventive medications can be a very effective part of a migraine treatment plan, says Jarrard. “These days, we have so many treatment options,” he says.

Acute vs. Preventive Migraine Treatment

Acute treatment is what you take as soon as you feel a migraine attack starting, while preventive treatment is taken on a regular schedule to prevent attacks in the first place, says Joshua Tobin, MD, a neurologist at Banner Health in Phoenix, who specializes in headache and migraine.

The goal of preventive treatment is fewer migraine days, less severe attacks, and less reliance on acute medication.

 Not only can reducing migraine burden improve quality of life but it can also help reduce the risk of medication-overuse headache.

“If people have frequent headache attacks or migraine attacks and they’re taking their as-needed medications — even over-the-counter drugs — too frequently, it can actually make their headaches worse over time and make them more frequent,” says Jarrard.

When to Consider Preventive Treatment

Preventive treatment is often underused, even among people who would likely benefit from it, says Jarrard.

“Research has shown that if you have four or more migraine days a month, you will likely benefit from a prevention medication,” he says. That fits with guidance from the American Headache Society, which recommends considering prevention when attacks are frequent, when acute treatments are not working well enough or are being overused, or when migraine is especially disabling.

Frequency is not the only thing that matters when deciding to add preventive treatment, however. “Even someone with fewer attacks may benefit from preventive drugs if those attacks are especially disruptive or hard to treat,” says Jarrard.

The same goes when acute treatment is falling short — adding a preventive drug may help, says Dr. Tobin.

The roster of preventive migraine treatments has a lot more variety than it did a few years ago. “The newer medications are truly game changers in our field,” says Jarrard. The best option — or options — for each person often depends on symptoms, other health conditions, and the overall response to the treatment.

Traditional Preventive Therapies

Many older preventive drugs were not originally developed for migraine. Doctors have long borrowed them from other areas of medicine because they can reduce attacks in some people, and they can be especially helpful when someone has another condition that the drug may help manage, such as high blood pressure, insomnia, anxiety, depression, or tremor.

Beta-Blockers These blood pressure drugs are thought to help steady the overactive nerve and blood vessel signaling involved in migraine. They include the following:

  • propranolol (Inderal LA, InnoPran XL)
  • metoprolol (Lopressor, Toprol-XL)
  • timolol
Side effects can include fatigue, dizziness, low blood pressure, and worsening asthma symptoms in some people.

Anticonvulsants These seizure medicines can help prevent migraine by dampening abnormal nerve excitability. They include the following:

  • topiramate (Topamax, Qudexy XR, others)
  • valproate
Topiramate can cause tingling, weight changes, and cognitive side effects such as brain fog and trouble finding words. Valproate can cause nausea, dizziness, and weight changes. Neither topiramate nor valproate is recommended in people who are pregnant or trying to get pregnant.

Antidepressants Some antidepressants can help prevent migraine, especially when someone also has depression, anxiety, or sleep problems.

  • Tricyclic Antidepressants (TCAs) These older antidepressants affect brain chemicals involved in pain signaling and are commonly used for migraine prevention, especially when sleep problems are also part of the picture. They include amitriptyline and nortriptyline; common side effects can include drowsiness, dry mouth, constipation, and weight gain.

  • Serotonin and Norepinephrine Reuptake Inhibitor (SNRI) The SNRIs venlafaxine (Effexor XR) and duloxetine (Cymbalta) work differently from TCAs and may be a good option for someone who also has depression or anxiety; possible side effects can include nausea and fatigue.

While these older medications can be effective, the side effects — especially for TCAs — can be pretty unpleasant, says Jarrard.

Newer Preventive Therapies

The newer options were designed more specifically around the changes in the brain that lead to migraine.

Research shows that CGRP-targeting therapies, which include both monoclonal antibodies and gepants, are among the most effective preventive options for episodic migraine, and they are generally better tolerated than older drugs like topiramate and propranolol.

Frequency determines whether migraine is chronic or episodic. More than 15 headache days per month, with at least eight that include migraine features, for more than three months, is considered chronic. Less frequent, episodic migraine can worsen into chronic migraine.

CGRP Inhibitors (Monoclonal Antibodies) These drugs were developed specifically for migraine prevention. They block the protein CGRP or its receptor, interrupting a pathway strongly linked to migraine attacks. The following are in this class of drugs:

  • erenumab-aooe (Aimovig)
  • fremanezumab-vfrm (Ajovy)
  • galcanezumab-gnlm (Emgality)
  • eptinezumab-jjmr (Vyepti)

“CGRP is a substance that is released in large quantities on the surface of the brain at the start of a migraine,” says Tobin. The drugs do not stop CGRP from being released, but they block it from activating the pathway that helps trigger migraine.

Most CGRP Inhibitors are given monthly or every three months by injection or infusion. The most common side effect is a reaction at the injection site, though constipation and fatigue can also occur.

Atogepant (Qulipta)
Atogepant is an oral gepant used only for prevention.

“Atogepant attaches to the CGRP receptor, preventing CGRP from activating it,” says Tobin. Data suggests that the drug’s benefit can increase over time.

Potential side effects include nausea, constipation, and fatigue.

Botox Injections of onabotulinumtoxinA (Botox) in the head, neck, and shoulders can lower the frequency and intensity of migraine.

Injections last about 12 weeks, which is one drawback: Patients need to see their provider more often than for other medications.

“We definitely feel extraordinarily comfortable with Botox, because it’s been approved by the U.S. Food and Drug Administration [FDA] for migraine for over 15 years,” says Jarrard.

Neuromodulation

Neuromodulation devices use electrical or magnetic stimulation rather than medication. They stimulate nerves to change how the brain processes pain. Therapies include transcutaneous supraorbital nerve stimulation, external vagal nerve stimulation, distal transcutaneous electrical stimulation, combined occipital and trigeminal neurostimulation, and single-pulse transcranial magnetic stimulation.

For prevention, FDA-cleared devices include the following:

  • Cefaly
  • Savi Dual
  • GammaCore
  • Nerivio
  • HeadaTerm 2

These devices can be appealing for people who want to avoid medication side effects or need a nondrug option. But in practice, access can be a major barrier.

“I tend to be cautious about neuromodulation, primarily due to cost considerations and the challenges that many patients face obtaining insurance coverage for these devices,” says Tobin. “While the clinical data certainly supports their effectiveness, the practical reality is that many patients can’t access them.”

What to Expect From Preventive Migraine Treatments

No prevention treatment is likely to prevent all migraine attacks.

“Our ultimate goal is fewer migraine days, less disability, and more control,” says Jarrard, adding that preventive treatment can also make migraine attacks less severe and make rescue medicine work better.

That improvement usually takes time. The American Headache Society recommends giving a preventive treatment a fair trial — often at least two months at a target dose — because benefits may build gradually rather than all at once. A realistic benchmark is often about a 50 percent reduction in migraine frequency, not total elimination.

How much relief a person gets depends on the treatment and the individual’s response to it. Evidence suggests that preventive medications often reduce monthly migraine days by about three or four days a month in clinical trials.

It is possible to take more than one preventive treatment at a time. The medications would be prescribed in a stepwise manner so that the effectiveness of each drug is clear. But there aren’t many trials that show adding two preventive medications is more effective than either medication alone.

A meta-analysis of preventive treatments found that adding a second drug may further decrease headache days, but it typically caused more side effects.

Bottom line: If your migraine attacks are bothering you and aren’t well managed with your acute medication, it’s a good idea to talk with your provider about preventive medications, says Jarrard.

The Takeaway

  • If migraine attacks are happening often, are especially disruptive, or are getting harder to control with acute medicine alone, it may be time to ask your doctor about preventive treatment.
  • Preventive treatment does not stop every migraine attack, but it can lead to fewer migraine days, less severe attacks, and less need for acute medication.
  • There are more options than there used to be, including newer CGRP-targeting therapies, Botox, and neuromodulation devices, so treatment can be tailored to each individual.
EDITORIAL SOURCES
Everyday Health follows strict sourcing guidelines to ensure the accuracy of its content, outlined in our editorial policy. We use only trustworthy sources, including peer-reviewed studies, board-certified medical experts, patients with lived experience, and information from top institutions.
Resources
  1. Migraine: Diagnosis and Treatment. Mayo Clinic. July 8, 2025.
  2. Ailani J et al. The American Headache Society Consensus Statement: Update on Integrating New Migraine Treatments Into Clinical Practice. Headache. June 23, 2021.
  3. Vélez-Jiménez M et al. Comprehensive Preventive Treatments for Episodic Migraine: a Systematic Review of Randomized Clinical Trials. Frontiers in Neurology. August 17, 2025.
  4. Lampl C et al. The Comparative Effectiveness of Migraine and Preventive Drugs: a Systematic Review and Network Meta-Analysis. The Journal of Headache and Pain. May 19, 2023.
  5. American Migraine Foundation. Understanding Chronic Migraine. February 12, 2018.
  6. Botox for Migraines. Cleveland Clinic. October 29, 2025.
  7. What Is the Role of Neuromodulation? American Migraine Foundation. September 24, 2025.
  8. Lipton RB et al. What Is Combination Treatment in Migraine? Moving Toward a Uniform Definition of a Familiar Principle. Neurology and Therapy. October 15, 2024.

Michael Yang, MD

Medical Reviewer

Dr. Michael Yang is a neurologist and headache specialist at Emplify Health, and an adjunct professor of neurology at the University of Wisconsin Madison School of Medicine.

He comp...

Becky Upham, MA

Becky Upham

Author

Becky Upham has worked throughout the health and wellness world for over 25 years. She's been a race director, a team recruiter for the Leukemia and Lymphoma Society, a salesperson...